Graduate student Jianqin Lu has been selected for a podium presentation at the 41st Annual Meeting & Exposition of the Controlled Release Society to be held in Chicago, Illinois, July 13-16, 2014. The title of Jianqin Lu’s presentation is Folate-conjugated PEG-derivatized Embelin as A Versatile Nanocarrier for the Targeted Delivery of Doxorubicin with Reversal of Multidrug Resistance.
Lu is a student in the pharmaceutics track, department of pharmaceutical sciences at the School of Pharmacy. His primary advisor is Song Li, MD, PhD.
This article has no comments